CVS is changing its strategy: Smaller stores, more emphasis on pharmacy services

CVS, one of the largest pharmacy chains in the US, has decided to change its strategy and focus on shrinking its stores. The move is part of a broader turnaround plan for the company, which is in a period of transformation. It will open about a dozen new stores this year that will be half the size of its traditional stores and focus only on pharmacy products, eliminating the traditional store front that typically offers candy, gift cards and other consumer goods.

Focus on pharmacies instead of retail

The reduction in store size is just one of the steps $CVS is taking to adapt to current industry changes. In addition to new smaller stores, the company plans to close more than 1,000 locations and lay off thousands of employees. The move is a response to the challenges facing drugstore chains like CVS, which have experienced intense competition from giants like Amazon, Target and Walmart in recent years, while also dealing with rising crime rates that have negatively impacted their profitability.

The smaller-sized stores will focus primarily on full-service pharmacy services and some commonly available products, a CVS spokesman said. "These stores will be designed to meet the specific needs of communities in the pharmacy industry," a company representative said. He said the goal is to tailor the size and assortment of the stores to the specific needs of local customers and improve the availability of pharmacy services in different geographic areas.

Challenges for traditional pharmacy chains

This trend shows that CVS is trying to focus its efforts on defending revenue from the pharmacy side of its business. Neil Saunders, an analyst at GlobalData Retail, pointed out that focusing only on pharmacies means that CVS has done "very little to defend the revenue from the retail side of its business." He said it is cheaper to run smaller stores that focus on core products, but this is not a complete solution for CVS as digital competitors and competition from chains such as Walmart continue to grow in the market.

The move is not unique, however. Other major drugstore chains are facing similar issues. Last week, for example, Walgreens Boots Alliance announced it was selling itself to a private equity firm in a deal worth $24 billion. The company thus shed its status as a publicly traded company after more than a century. In addition, even competitor Rite Aid recently went through bankruptcy and closed hundreds of stores.

Overall, then, the pharmacy sector is experiencing a period of change in which companies like CVS are struggling to adapt to new conditions and competition, which may mean not only changes in store size but also a fundamental rethinking of business strategies.

Disclaimer: You will find a lot of inspiration on Bulios, but stock selection and portfolio construction is up to you, so always conduct a thorough analysis of your own.

Source: CNN